Stefanie Thiel

Title: Inventor Stefanie Thiel: Pioneering Innovations in Pharmaceutical Compositions

Introduction

Stefanie Thiel, an accomplished inventor hailing from Binzen, Germany, has made significant contributions to the field of pharmaceuticals. With a total of two patents to her name, Thiel is dedicated to developing innovative solutions aimed at improving medication delivery and effectiveness.

Latest Patents

Thiel's most recent patents focus on advanced pharmaceutical granulations that contain a gamma-hydroxybutyric acid derivative. These inventions detail unique modified release compositions that feature functional coatings surrounding a core ingredient, specifically 4-((L-valyl)oxy)butanoic acid. The innovative functional coatings facilitate either immediate release or modified release of the active ingredient, which can be utilized in oral pharmaceutical compositions.

Career Highlights

As an inventor working at XWPharma Ltd., Stefanie Thiel brings her expertise in pharmaceutical sciences to the forefront of medicinal innovation. Her patents reflect a deep understanding of the complexities involved in drug formulation and release mechanisms, showcasing her commitment to enhancing therapeutic options available to patients.

Collaborations

Throughout her career, Thiel has had the privilege of collaborating with talented individuals such as Sami Karaborni and Daniel M. Canafax. These partnerships have enriched her research endeavors, leading to groundbreaking advancements in the realm of pharmaceutical granulation technologies.

Conclusion

Stefanie Thiel exemplifies the spirit of innovation within the pharmaceutical industry. Her contributions through her patents not only highlight her ingenuity as an inventor but also reflect a broader commitment to improving health outcomes through advanced drug formulations. As she continues to work at XWPharma Ltd., the impact of her inventions is poised to further enhance the landscape of pharmaceutical development.